Clinical Trial Update: Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study of haploidentical, T-cell depleted transplantation in high-risk sickle cell disease; the trial is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Haploidentical T-cell depleted transplantation

Snippet

Sponsor: New York Medical College | Conditions: Sickle Cell Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING